SHOX2 and cancer: In group 3, five of seven early stage I cancer-adjacent but not cancer specimen exhibited the hypermethylation of SHOX2 or RASSF1A. A possible explanation for this could be the low cancer cells’ proportion in the left-over FFPE specimen of early small lesions.